You Validate the Science. Now Validate Market Readiness.
Every company believes they’re ready for launch—until the market proves otherwise.
Clinical data, funding, and TAM slides don’t guarantee adoption. They create confidence. But internal confidence isn’t market conviction. The market won’t move until it believes.
That’s where the PCDR comes in. It’s belief engineering—the new due diligence for commercial success.
Validate market readiness before launch and you don’t just launch a product.
You launch a category.
Category leaders capture 76% of the market valuation.
Over three weeks, we’ll uncover the belief gaps standing between your product and market adoption.
Week 1: Expose
internal assumptions that create false confidence
Week 2: Reveal
the market’s belief gaps that threaten adoption
Week 3: Confront
the truth about launch readiness before millions get spent scaling the wrong story
Your Launch: Ready? (…Or not?)
You’ll walk away with the three artifacts every board should demand before launch:
Launch Fragility Index
Where your launch assumptions are most at risk—and what’s safe to scale.
Belief Deficit Map
A new lens to see the gap between product readiness and market readiness.
Launch Readiness Scorecard
The go/no-go clarity boards and investors demand before millions are spent.
One Seat. One Shot. Will It Be Yours?
The PCDR pilot is a rare opportunity to safeguard your launch—and set the new standard for belief-driven adoption in healthcare.
Only one company will be selected to receive a full $100K PCDR at no cost.
If you are chosen, you will set the standard for how boards protect capital, safeguard valuation, and scale belief before revenue.
Still have questions? Feel free to reach out: Holley@greymattermarketing.com